Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Close this folder5. Planning resources
View the document5.1 The first steps in planning
View the document5.2 Identify what is already available or accessible
View the document5.3 Make a realistic assessment of additional needs
Open this folder and view contents5.4 Human resources: who will do the work?
View the document5.5 Maintaining the motivation of contributors
View the document5.6 Material resources - an office, equipment and references
View the document5.7 Financial resources - the key to sustainability
View the document5.8 Long-term sustainability
View the document5.9 Cost-saving strategies
View the document5.10 Key messages for starting a drug bulletin
View the document5.11 References
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information

5.2 Identify what is already available or accessible

First find out what is already available locally in terms of human resources, publications and offices. It may be possible to make use of these with little or no expense.

Valuable sources of information include other bulletins, local or national drug formularies, standard treatment guidelines or protocols, selected medical and pharmaceutical journals and books. It may be worth developing links with universities, medical and pharmaceutical associations, research centres, libraries, consumer organizations, government departments and non-governmental organizations, depending on their degree of independence and reliability. Duplication of expensive resources should be avoided, particularly in developing countries.

You may want to get to know the people who are in charge of these different organizations and seek their cooperation. They could help you with their experience and materials and may also provide some financial support. Try to explore areas that could be of mutual interest and strive for cooperation instead of seeking competition with others in the same field (see Chapter 13). Being linked with established organizations, such as teaching institutions, hospitals or drug information centres, when they have credibility, can be an advantage for bulletins in terms of human, financial, material and administrative resources. Such links can also provide moral support from ideological allies.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017